Trexquant Investment LP Dynavax Technologies Corp Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

A detailed history of Trexquant Investment LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Trexquant Investment LP holds 521,992 shares of DVAX stock, worth $6.99 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
521,992
Holding current value
$6.99 Million
% of portfolio
0.08%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$10.05 - $11.61 $5.25 Million - $6.06 Million
521,992 New
521,992 $5.81 Million
Q1 2024

May 14, 2024
SELL
$11.7 - $14.98 $204,340 - $261,625
-17,465 Reduced 6.62%
246,447 $3.06 Million
Q4 2023

Feb 09, 2024
BUY
$13.09 - $14.98 $1.17 Million - $1.34 Million
89,521 Added 51.33%
263,912 $3.69 Million
Q3 2023

Nov 13, 2023
BUY
$12.64 - $14.99 $1.19 Million - $1.41 Million
94,205 Added 117.48%
174,391 $2.58 Million
Q2 2023

Aug 11, 2023
SELL
$9.85 - $13.17 $193,345 - $258,513
-19,629 Reduced 19.67%
80,186 $1.04 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $1.19 Million - $1.49 Million
-125,778 Reduced 55.75%
99,815 $979,000
Q4 2022

Feb 13, 2023
BUY
$10.27 - $13.29 $1.86 Million - $2.41 Million
181,543 Added 412.13%
225,593 $2.4 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $437,416 - $768,232
44,050 New
44,050 $460,000
Q2 2022

Aug 11, 2022
SELL
$7.45 - $12.83 $1.62 Million - $2.8 Million
-217,975 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$9.75 - $14.44 $871,640 - $1.29 Million
89,399 Added 69.53%
217,975 $2.36 Million
Q4 2021

Feb 14, 2022
BUY
$13.17 - $20.94 $1.51 Million - $2.41 Million
114,917 Added 841.33%
128,576 $1.81 Million
Q3 2021

Nov 12, 2021
SELL
$9.16 - $19.83 $297,205 - $643,404
-32,446 Reduced 70.37%
13,659 $262,000
Q2 2021

Aug 12, 2021
BUY
$7.25 - $10.99 $334,261 - $506,693
46,105 New
46,105 $454,000
Q4 2020

Feb 11, 2021
SELL
$3.73 - $5.6 $226,769 - $340,457
-60,796 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$4.32 - $11.7 $262,638 - $711,313
60,796 New
60,796 $263,000
Q1 2018

May 03, 2018
SELL
$14.65 - $19.9 $404,003 - $548,782
-27,577 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$17.3 - $24.08 $477,082 - $664,054
27,577
27,577 $516,000

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.69B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email